By Josh Beckerman
Haoxi Health Technology shares fell to their lowest point yet after the company reported the pricing of a $12 million equity offering.
The stock was recently down 75% to 76 cents, with an intraday low of 60 cents. Haoxi Health Technology's January initial public offering of 2.4 million shares priced at $4 each.
Haoxi Health Technology, which provides healthcare-focused online marketing services in China, said Thursday that it sold 4 million units for $3 each.
Each unit consists of one share or pre-funded warrant, one Series A warrant and one Series B warrant.
The Series A warrant is exercisable immediately upon issuance, while the Series B warrant is exercisable on or after the 16th calendar day from closing. On the Series B exercise date, the maximum number of shares issuable upon exercise of the Series A warrant will be adjusted to 20 million.
The maximum number of shares issuable upon exercise of the Series B warrants will be 16 million.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
September 19, 2024 15:05 ET (19:05 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments